TITLE

Vasectomy vs. cancer

AUTHOR(S)
Podolsky, Doug; Baig, Edward C.
PUB. DATE
March 1993
SOURCE
U.S. News & World Report;3/1/93, Vol. 114 Issue 8, p71
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports that two Harvard studies suggested that men who have their sperm-carrying tubes snipped face a risk of prostate cancer 60 percent higher than unvasectomized men do. The increased risk jumps to between 80 and 90 percent 20 years after the vasectomy. Study results; No plausible explanations for a vasectomy-cancer link; More.
ACCESSION #
9302250648

 

Related Articles

  • Pharmacologic prevention of prostate cancer.  // Patient Care;7/15/1995, Vol. 29 Issue 12, p205 

    Informs about the success of an experiment done by S. Tsukamoto, H. Akaza and S. Imada to study the impact of prostate carcinogens, casodex and finasteride on prostate cancer development in rats. Reasons for not transplanting the results of the experiment directly to humans; Study published in...

  • Volunteers sought for prostate cancer study.  // FDA Consumer;Jan/Feb94, Vol. 28 Issue 1, p5 

    Informs that the National Cancer Institute (NCI) and Southwest Oncology Group, San Antonio, Texas, are seeking 18,000 healthy men over age 55 to participate in the first large-scale prevention trial for prostate cancer. Details of the Prostate Cancer Prevention Trial; Expected new cases of...

  • Risky business.  // Time;3/1/1993, Vol. 141 Issue 9, p17 

    Cites a pair of reports in the `Journal of the American Medical Association' which say men who have had vasectomies are 1 1/2 times more likely to develop prostate cancer as men who have not had the operation. Harvard's Edward Giovannucci, who directed both studies, speculates the reduction in...

  • PSA Elevations After Prostate Cancer Radiotherapy. Kuritzky, Louis // Neurology Alert;Nov2012 Clinical Briefs In Primary Care, p21 

    The article discusses research by J. M. Crook and colleagues, published in a 2012 issue of the "New England Journal of Medicine" prostate cancer (PCA) recurrences after prostate cancer radiotherapy.

  • Study reveals protein marker for aggressive prostate cancer.  // Hudson Valley Business Journal;09/14/98-09/21/98, Vol. 9 Issue 10, p29 

    Focuses on the findings of a study about the level of a protein called p27 that may identify prostate cancer patients who need aggressive cancer treatment. Details on the p27 marker; Findings on the analysis of 130 prostate cancer specimens; Risk posed by surgical treatment of prostrate cancer.

  • Re: "Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial".  // American Journal of Epidemiology;Dec2011, Vol. 174 Issue 12, p1425 

    A correction to the article "Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial" that was published in the June 15, 2011 issue is presented.

  • Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin. Luo, Jun-Li; Tan, Wei; Ricono, Jill M.; Korchynskyi, Olexandr; Zhang, Ming; Gonias, Steven L.; Cheresh, David A.; Karin, Michael // Nature;2/12/2009, Vol. 457 Issue 7231, p920 

    An erratum is presented concerning the article "Nuclear cytokine-activated IKKa controls prostate cancer metastasis by repressing Maspin," published in volume 446, pages 690 - 694.

  • Dying for dollars. Jaffe, Harry // Men's Health;Sep97, Vol. 12 Issue 7, p132 

    Focuses on the researches of Mike Manyak and Steve Patierno to find a cure for prostate cancer and to search funds for these researches. Goal of the research of Manyak and Patierno; Initial findings of their research; How the constant hunt for funds diverts their attention from basic research;...

  • Urology working its way into public consciousness. Gatty, Bob // Urology Times;Nov97, Vol. 25 Issue 11, p2 

    Talks about the recognition of urology in Washington. Support of legislators on the importance of early detection and new developments in treatment; Amount given by the Department of Defense (DOD) for prostate cancer research; Other organization which funded urology research.

Share

Read the Article

Other Topics